Bionic women and men - Part 3: Right ventricular dysfunction in patients implanted with left ventricular assist devices.
Manreet K KanwarBarry J McDonnellHannah RosenblumJohn R CockcroftEric J StöhrWilliam K CornwellPublished in: Experimental physiology (2020)
The adaptation of the right ventricular (RV) output to a left ventricular assist device (LVAD) often determines the fate of patients with pulmonary hypertension secondary to left heart failure. Pre-existing right heart dysfunction in patients with advanced left heart failure is the consequence of increased (arterial) afterload and not simply the consequence of myocardial disease. If unaccounted for, it has the potential of accelerating into clinical right heart failure after LVAD, leading to significant morbidity and mortality. After LVAD implantation, the RV has to face increased flow generated by the LVAD, cardiac arrhythmias and exaggerated functional interactions between both ventricles. Understanding the key physiological mechanisms of RV dysfunction in patients with end-stage heart failure will allow us to predict and therefore prevent RV failure after LVAD implantation.
Keyphrases
- heart failure
- left ventricular assist device
- left ventricular
- mycobacterium tuberculosis
- cardiac resynchronization therapy
- pulmonary hypertension
- hypertrophic cardiomyopathy
- oxidative stress
- acute heart failure
- end stage renal disease
- acute myocardial infarction
- atrial fibrillation
- aortic stenosis
- mitral valve
- left atrial
- newly diagnosed
- ejection fraction
- chronic kidney disease
- adipose tissue
- prognostic factors
- patient reported outcomes
- pulmonary artery
- metabolic syndrome
- pregnant women
- congenital heart disease
- pulmonary arterial hypertension
- human health
- acute coronary syndrome